CIK 0001099219
- Large accelerated filer
METLIFE INC
Sign in to watch- Ticker
- MET
- Exchange
- NYSE
- Industry
- Life Insurance
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 134075851
- Phone
- +1 212-578-5500
- Business address
- 200 PARK AVENUE, NEW YORK, NY, 10166
Securities
- MET Common Stock NYSE
- MET-PA Preferred Series A Floating Rate NYSE
- MET-PE Depositary Shares NYSE
- MET-PF Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,298,702
- in 1 filing
Net −$19,298,702. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Harris Carla A Director | Grant or award | +535 | $81.78 | $44K | 7,336 |
| 2025-01-02 | MCKENZIE DIANA Director | Grant or award | +535 | $81.78 | $44K | 20,667 |
| 2025-01-02 | Kennard William E Director | Grant or award | +535 | $81.78 | $44K | 41,907 |
| 2024-12-16 | Johnson Jeh C. Director | Grant or award | +33 | $82.74 | $3K | 5,069 |
| 2024-12-16 | Herzog David L Director | Grant or award | +39 | $82.74 | $3K | 25,340 |
| 2024-12-16 | Kennard William E Director | Grant or award | +271 | $82.74 | $22K | 41,372 |
| 2024-12-16 | Hay Laura J Director | Grant or award | +13 | $82.74 | $1K | 2,023 |
| 2024-12-16 | MCKENZIE DIANA Director | Grant or award | +132 | $82.74 | $11K | 20,132 |
| 2024-12-16 | GRISE CHERYL W Director | Grant or award | +536 | $82.74 | $44K | 86,541 |
| 2024-12-16 | HUBBARD ROBERT GLENN Director | Grant or award | +579 | $82.74 | $48K | 96,410 |
| 2024-12-16 | KELLY EDWARD J III Director | Grant or award | +232 | $82.74 | $19K | 35,523 |
| 2024-12-16 | Harris Carla A Director | Grant or award | +16 | $82.74 | $1K | 6,801 |
| 2024-12-13 | DEBEL MARLENE EVP & Chief Risk Officer | Exercise or conversion | +13,107 | $34.33 | $450K | 121,614 |
| 2024-12-13 | DEBEL MARLENE EVP & Chief Risk Officer | Exercise or conversion | +9,703 | $45.91 | $445K | 131,317 |
| 2024-12-13 | DEBEL MARLENE EVP & Chief Risk Officer | Sale | −22,810 | $82.88 | $1.9M | 108,507 |
| 2024-12-13 | DEBEL MARLENE EVP & Chief Risk Officer | Exercise or conversion · Employee Stock Options (right to buy) | −13,107 | 0 | ||
| 2024-12-13 | DEBEL MARLENE EVP & Chief Risk Officer | Exercise or conversion · Employee Stock Options (right to buy) | −9,703 | 0 | ||
| 2024-12-13 | Khalaf Michel President & CEO | Exercise or conversion | +26,138 | $45.91 | $1.2M | 521,725 |
| 2024-12-13 | Khalaf Michel President & CEO | Sale | −20,926 | $82.84 | $1.7M | 500,799 |
| 2024-12-13 | Khalaf Michel President & CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −26,138 | 0 |
Page 12 of 13 · 243 trades